Literature DB >> 11734239

Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear.

M A Nobbenhuis, T J Helmerhorst, A J van den Brule, L Rozendaal, F J Voorhorst, P D Bezemer, R H Verheijen, C J Meijer.   

Abstract

We studied the natural course of high-risk human papillomavirus (HPV) infection and cytological regression in women referred for colposcopy because of abnormal cervical smears. We found that high-risk HPV clearance preceded regression of cervical lesions by an average of 3 months. The cumulative 1-year rate of cytological regression was similar in women with mild and moderate dyskaryotic cervical smears. Thus, retesting of high-risk HPV after 6 months in women with mild to moderate dyskaryosis predicts cytological regression.

Entities:  

Mesh:

Year:  2001        PMID: 11734239     DOI: 10.1016/S0140-6736(01)06809-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  41 in total

1.  Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting.

Authors:  Sarah Coseo Markt; Ana C Rodriguez; Robert D Burk; Allan Hildesheim; Rolando Herrero; Sholom Wacholder; Martha Hutchinson; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters.

Authors:  Jacqueline M Vink; Folkert J van Kemenade; Chris J L M Meijer; Mariel K Casparie; Gerrit A Meijer; Dorret I Boomsma
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

3.  Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies.

Authors:  R Tachezy; I Mikysková; V Ludvíková; L Rob; T Kucera; V Slavík; A Beková; H Robová; M Pluta; E Hamsíková
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

Review 4.  Human papillomavirus in cervical cancer.

Authors:  F Xavier Bosch; Silvia de Sanjosé
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

5.  Hydrogen peroxide producing lactobacilli in women with cervical neoplasia.

Authors:  Ho Sun Choi; Ki Min Kim; Chol Hong Kim; Seok Mo Kim; Jong Seok Oh
Journal:  Cancer Res Treat       Date:  2006-04-30       Impact factor: 4.679

Review 6.  [HPV infection in women : Diagnostics, treatment and the relevance of vaccination].

Authors:  F Kleinsorge; M Schmidmayr
Journal:  Urologe A       Date:  2018-12       Impact factor: 0.639

Review 7.  Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.

Authors:  Sjoerd H van der Burg; Joel M Palefsky
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

Review 8.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

9.  Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.

Authors:  Luisa Barzon; Colomba Giorgi; Franco M Buonaguro; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2008-12-16       Impact factor: 2.965

10.  Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.

Authors:  Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2010-01-11       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.